Antinuclear antibodies during psoralens plus ultraviolet A (PUVA) therapy—are they worthwhile?
- 1 March 1987
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 16 (3) , 574-577
- https://doi.org/10.1016/s0190-9622(87)70076-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Disseminated superficial actinic porokeratosis: Appearance associated with photochemotherapy for psoriasisJournal of the American Academy of Dermatology, 1985
- Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapyJournal of the American Academy of Dermatology, 1983
- Antinuclear and anticytoplasmic antibodies: Concepts and misconceptionsJournal of the American Academy of Dermatology, 1983
- Serologic studies in patients with lupus erythematosus and psoriasisJournal of the American Academy of Dermatology, 1983
- Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA)Journal of the American Academy of Dermatology, 1982
- Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patientsJournal of the American Academy of Dermatology, 1982
- Risk of Cutaneous Carcinoma in Patients Treated with Oral Methoxsalen Photochemotherapy for PsoriasisNew England Journal of Medicine, 1979
- Induction of antinuclear antibodies by ultraviolet irradiation.Annals of the Rheumatic Diseases, 1970
- STUDIES ON THE PHOTO‐C4‐CYCLO‐ADDITION REACTIONS BETWEEN SKIN‐PHOTOSENSITIZING FUROCOUMARINS AND NUCLEIC ACIDS*Photochemistry and Photobiology, 1970
- Procainamide‐induced serologic changes in asymptomatic patientsArthritis & Rheumatism, 1969